Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Gallian

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Vox Sanguinis|September 11, 2023
Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillanceSyria Laperche, Claire Sauvage, Pierre Gallian, et al.
Vox Sanguinis|December 13, 2021
COVID-19 convalescent plasma: Evolving strategies for serological screening in FrancePierre Gallian, Sophie Le Cam, Nadège Brisbarre, et al.
Medicine|January 12, 2005
Ectoparasitism and vector-borne diseases in 930 homeless people from MarseillesPhilippe Brouqui, Andreas Stein, Hervé Tissot Dupont, et al.
Transfusion|April 25, 2009
Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panelsAzzedine Assal, Valérie Barlet, Marie Deschaseaux, et al.
Blood Transfusion = Trasfusione Del Sangue|August 15, 2022
Seven years (2015-2021) of blood donor screening for HEV-RNA in France: lessons and perspectivesSyria Laperche, Claude Maugard, Sébastien Lhomme, et al.
Plos Neglected Tropical Diseases|June 6, 2015
Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of CongoNanikaly Moyen, Laurence Thirion, Petra Emmerich, et al.
Transfusion|January 28, 2022
Low rate of RNAemia in blood donations collected during the first wave of COVID-19 in FranceSophie Le Cam, Pierre Gallian, Céline Ricard, et al.
Iscience|February 23, 2023
SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021Pierre Gallian, Nathanaël Hozé, Nadège Brisbarre, et al.
Blood Transfusion = Trasfusione Del Sangue|June 1, 2021
Effectiveness of the HCV blood screening strategy through eighteen years of surveillance of HCV infection in blood donors in FrancePierre Cappy, Laure Boizeau, Daniel Candotti, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 24, 2024
New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24Marlène Guillet, Ariane Bas, Marjorie Lacoste, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Vox Sanguinis|September 11, 2023
Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillanceSyria Laperche, Claire Sauvage, Pierre Gallian, et al.
Vox Sanguinis|December 13, 2021
COVID-19 convalescent plasma: Evolving strategies for serological screening in FrancePierre Gallian, Sophie Le Cam, Nadège Brisbarre, et al.
Medicine|January 12, 2005
Ectoparasitism and vector-borne diseases in 930 homeless people from MarseillesPhilippe Brouqui, Andreas Stein, Hervé Tissot Dupont, et al.
Transfusion|April 25, 2009
Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panelsAzzedine Assal, Valérie Barlet, Marie Deschaseaux, et al.
Blood Transfusion = Trasfusione Del Sangue|August 15, 2022
Seven years (2015-2021) of blood donor screening for HEV-RNA in France: lessons and perspectivesSyria Laperche, Claude Maugard, Sébastien Lhomme, et al.
Plos Neglected Tropical Diseases|June 6, 2015
Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of CongoNanikaly Moyen, Laurence Thirion, Petra Emmerich, et al.
Transfusion|January 28, 2022
Low rate of RNAemia in blood donations collected during the first wave of COVID-19 in FranceSophie Le Cam, Pierre Gallian, Céline Ricard, et al.
Iscience|February 23, 2023
SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021Pierre Gallian, Nathanaël Hozé, Nadège Brisbarre, et al.
Blood Transfusion = Trasfusione Del Sangue|June 1, 2021
Effectiveness of the HCV blood screening strategy through eighteen years of surveillance of HCV infection in blood donors in FrancePierre Cappy, Laure Boizeau, Daniel Candotti, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 24, 2024
New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24Marlène Guillet, Ariane Bas, Marjorie Lacoste, et al.
Pageof 9